🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
The purpose of this study is to evaluate the safety, performance and usabil...
Status
Completed
Location
Oklahoma University
Start Date
2013-11
Trial ID
NCT01851772
Treatments Being Tested
This is a patient-sponsored study that evaluates the safety and efficacy of...
Status
Unknown
Location
Makati Medical Center
Start Date
2015-05-29
Trial ID
NCT03113162
Treatments Being Tested
This is a multicentre, open-label, phase II study of ibrutinib 560 mg in co...
Status
Unknown
Location
National University Hospital Singapore
Start Date
2016-12-13
Trial ID
NCT02955628
Treatments Being Tested
This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Start Date
2025-09-01
Trial ID
NCT07117305
Treatments Being Tested
This randomized phase III trial is comparing the effectiveness of three adj...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2003-10-15
Trial ID
NCT00068692
Treatments Being Tested
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
In this double-blind, randomized, sham-controlled trial, the investigators ...
Status
Completed
Location
Tri-service general hospital
Start Date
2023-03-29
Trial ID
NCT06372834
Treatments Being Tested
The goal of this clinical trial is to find out if adding a PD-1 antibody (s...
Status
Not Yet Recruiting
Location
Sun Yat-Sen University Cancer Center
Start Date
2025-12-29
Trial ID
NCT07277842
Treatments Being Tested
This is a phase I dose escalation study. Dose escalation will be via the tr...
Status
Completed
Location
UPMC Hillman Cancer Center - Radiation Oncology
Start Date
2012-03-23
Trial ID
NCT01360606
Treatments Being Tested